Nonetheless, a better understanding of the intricate molecular mechanisms involved in HER2-altered cancer cells in relation to tumor progression, angiogenesis, immune escape and treatment resistance is still necessary to develop even more efficient therapeutic strategies. Here, ERBB2 is linked to neoplasm.